mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.2 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.2 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.2 |